Browse > Article
http://dx.doi.org/10.5012/bkcs.2013.34.11.3243

Folate Receptor-Specific Positron Emission Tomography Imaging with Folic Acid-Conjugated Tissue Inhibitor of Metalloproteinase-2  

Kim, Sung-Min (Magnetic Resonance Research Center, Korea Basic Science Institute)
Choi, Naeun (Magnetic Resonance Research Center, Korea Basic Science Institute)
Hwang, Seungkyun (Magnetic Resonance Research Center, Korea Basic Science Institute)
Yim, Min Su (Magnetic Resonance Research Center, Korea Basic Science Institute)
Lee, Jung-Sik (Research Institute of BiocurePharm Co. Ltd.)
Lee, Sang-Mok (Research Institute of BiocurePharm Co. Ltd.)
Cho, Gyunggoo (Magnetic Resonance Research Center, Korea Basic Science Institute)
Ryu, Eun Kyoung (Magnetic Resonance Research Center, Korea Basic Science Institute)
Publication Information
Abstract
The tissue inhibitor of metalloproteinase-2 (TIMP-2) inhibits matrix metalloproteinases activity and modulates cellular proliferation and apoptosis. The human serum albumin-TIMP-2 with folic acid conjugate (termed HT2-folate) was synthesized to promote uptake through folate receptors (FRs), and a corresponding radio-labeled compound was prepared for tumor diagnosis by positron emission tomography (PET). $^{68}Ga$-NOTA-HT2-folate was synthesized from $^{68}Ga$ and the NOTA chelator with HT2-folate. The fusion protein was identified using MALDI-TOF mass spectrometry. The radioligand was prepared with a high radiochemical yield. Cell-surface association of $^{68}Ga$-NOTA-HT2-folate significantly increased over time in FR-positive tumor cells. In animal PET and biodistribution studies, tumor uptake was very high as early as 1 h after radioligand injection. Folate conjugation enhanced the selective receptor-targeting efficacy of HT2 in FRexpressing tumors, and its radioligand will be useful as an in vitro tool and for in vivo tumor diagnosis by PET imaging.
Keywords
Folic acid; Human serum albumin-TIMP-2; $^{68}Ga$-NOTA-HT2-folate; Tumor; Radioligand;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Malemud, C. J. Front. Biosci. 2006, 11, 1696-701.   DOI   ScienceOn
2 Mannello, F.; Gazzanelli, G. Apoptosis 2001, 6(6), 479-482.   DOI   ScienceOn
3 Murphy, A. N.; Unsworth, E. J.; Stetler-Stevenson, W. G. J. Cell Physiol. 1993, 157(2), 351-358.   DOI   ScienceOn
4 Gomez, D. E.; Alonso, D. F.; Yoshiji, H.; Thorgeirsson, U. P. Eur. J. Cell Biol. 1997, 74(2), 111-122.
5 Hajitou, A.; Sounni, N. E.; Devy, L.; Grignet-Debrus, C.; Lewalle, J. M.; Li, H.; Deroanne, C. F.; Lu, H.; Colige, A.; Nusgens, B. V.; Frankenne, F.; Maron, A.; Yeh, P.; Perricaudet, M.; Chang, Y.; Soria, C.; Calberg-Bacq, C. M.; Foidart, J. M.; Noel, A. Cancer Res. 2001, 61(8), 3450-3457.
6 Visse, R.; Nagase, H. Circ. Res. 2003, 92(8), 827-839.   DOI   ScienceOn
7 Raffetto, J. D.; Khalil, R. A. Biochem. Pharmacol. 2008, 75(2), 346-359.   DOI   ScienceOn
8 Seo, D. W.; Li, H.; Guedez, L.; Wingfield, P. T.; Diaz, T.; Salloum, R.; Wei, B. Y.; Stetler-Stevenson, W. G. Cell 2003, 114(2), 171-180.   DOI   ScienceOn
9 Sung, C.; Nardelli, B.; LaFleur, D. W.; Blatter, E.; Corcoran, M.; Olsen, H. S.; Birse, C. E.; Pickeral, O. K.; Zhang, J.; Shah, D.; Moody, G.; Gentz, S.; Beebe, L.; Moore, P. A. J. Interferon Cytokine Res. 2003, 23(1), 25-36.   DOI   ScienceOn
10 Halpern, W.; Riccobene, T. A.; Agostini, H.; Baker, K.; Stolow, D.; Gu, M. L.; Hirsch, J.; Mahoney, A.; Carrell, J.; Boyd, E.; Grzegorzewski, K. J. Pharm. Res. 2002, 19(11), 1720-1729.   DOI   ScienceOn
11 Yao, Z.; Dai, W.; Perry, J.; Brechbiel, M. W.; Sung, C. Cancer Immunol. Immunother 2004, 53(5), 404-410.   DOI
12 Kang, W. K.; Park, E. K.; Lee, H. S.; Park, B. Y.; Chang, J. Y.; Kim, M. Y.; Kang, H. A.; Kim, J. Y. Protein Expression and Purification 2007, 53(2), 331-338.   DOI   ScienceOn
13 Garin-Chesa, P.; Campbell, I.; Saigo, P. E.; Lewis, J. L., Jr.; Old, L. J.; Rettig, W. J. Am. J. Pathol. 1993, 142(2), 557-567.
14 Sudimack, J.; Lee, R. J. Adv. Drug Deliv. Rev. 2000, 41(2), 147-162.   DOI   ScienceOn
15 Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Anal. Biochem. 2005, 338(2), 284-293.   DOI   ScienceOn
16 Pan, X. Q.; Wang, H.; Lee, R. J. Pharm. Res. 2003, 20(3), 417-422.   DOI   ScienceOn
17 Ross, J. F.; Wang, H.; Behm, F. G.; Mathew, P.; Wu, M.; Booth, R.; Ratnam, M. Cancer 1999, 85(2), 348-357.   DOI
18 Ross, J. F.; Chaudhuri, P. K.; Ratnam, M. Cancer 1994, 73(9), 2432-2443.   DOI   ScienceOn
19 Muller, C.; Schibli, R.; Forrer, F.; Krenning, E. P.; de Jong, M. Nucl. Med. Biol. 2007, 34(6), 603-608.   DOI   ScienceOn
20 Ladino, C. A.; Chari, R. V.; Bourret, L. A.; Kedersha, N. L.; Goldmacher, V. S. Int. J. Cancer 1997, 73(6), 859-864.   DOI   ScienceOn
21 Lee, J. W.; Lu, J. Y.; Low, P. S.; Fuchs, P. L. Bioorg. Med. Chem. 2002, 10(7), 2397-2414.   DOI   ScienceOn
22 Gabizon, A.; Horowitz, A. T.; Goren, D.; Tzemach, D.; Mandelbaum-Shavit, F.; Qazen, M. M.; Zalipsky, S. Bioconjug Chem. 1999, 10(2), 289-298.   DOI   ScienceOn
23 Leamon, C. P.; Cooper, S. R.; Hardee, G. E. Bioconjug Chem. 2003, 14(4), 738-747.   DOI   ScienceOn
24 Lu, J. Y.; Lowe, D. A.; Kennedy, M. D.; Low, P. S. J. Drug. Target. 1999, 7(1), 43-53.   DOI   ScienceOn
25 Ward, C. M.; Acheson, N.; Seymour, L. W. J. Drug. Target. 2000, 8(2), 119-123.   DOI   ScienceOn
26 Ilgan, S.; Yang, D. J.; Higuchi, T.; Zareneyrizi, F.; Bayhan, H.; Yu, D.; Kim, E. E.; Podoloff, D. A. Cancer Biother. Radiopharm. 1998, 13(6), 427-435.   DOI   ScienceOn
27 Mathias, C. J.; Hubers, D.; Low, P. S.; Green, M. A. Bioconjug Chem. 2000, 11(2), 253-257.   DOI   ScienceOn
28 Leamon, C. P.; Parker, M. A.; Vlahov, I. R.; Xu, L. C.; Reddy, J. A.; Vetzel, M.; Douglas, N. Bioconjug Chem. 2002, 13(6), 1200-1210.   DOI   ScienceOn
29 Jeong, J. M.; Hong, M. K.; Chang, Y. S.; Lee, Y. S.; Kim, Y. J.; Cheon, G. J.; Lee, D. S.; Chung, J. K.; Lee, M. C. J. Nucl. Med. 2008, 49(5), 830-836.   DOI   ScienceOn
30 Choi, J. Y.; Jeong, J. M.; Yoo, B. C.; Kim, K.; Kim, Y.; Yang, B. Y.; Lee, Y. S.; Lee, D. S.; Chung, J. K.; Lee, M. C. Nuclear Medicine and Biology 2011, 38(3), 371-379.   DOI   ScienceOn
31 Antony, A. C. Annual Review of Nutrition 1996, 16, 501-521.   DOI   ScienceOn
32 Choi, N.; Kim, S. M.; Hong, K. S.; Cho, G.; Cho, J. H.; Lee, C.; Ryu, E. K. Biomaterials 2011, 32(29), 7151-7158.   DOI   ScienceOn
33 Fernandez, C. A.; Butterfield, C.; Jackson, G.; Moses, M. A. The Journal of Biological Chemistry 2003, 278(42), 40989-40995.   DOI   ScienceOn
34 Ross, T. L.; Honer, M.; Muller, C.; Groehn, V.; Schibli, R.; Ametamey, S. M. J. Nucl. Med. 2010, 51(11), 1756-1762.   DOI